Browsing Tag
CyanVac CVXGA
1 post
CyanVac’s nasal COVID-19 vaccine shows strong immune response in U.S. phase 1 clinical trial
CyanVac’s nasal COVID-19 vaccine shows strong mucosal immune response in U.S. phase 1 trial. Larger studies underway to assess full efficacy.